Dr. Jean-Frederic Colombel, MD

Dr. Colombel practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Colombel's NPI, 1356783989, was assigned on July 24, 2013. Dr. Colombel graduated from Other in 1984. Dr. Colombel holds New York license 270631.

Dr. Colombel's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Colombel also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Colombel's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Colombel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Colombel practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Colombel's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Colombel is licensed in New York.

CMS data shows 57 Medicare services from Dr. Colombel across 1 procedure code in 2024, all of them office visits, for 53 Medicare patients. Medicare paid $4,188 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Colombel in 2024. The largest group is 65 to 74, with 25 patients. 68% of them have high cholesterol, and 66% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Colombel's median patient age at 41, with 41% women.

In 2024, Dr. Colombel wrote 156 Medicare Part D claims for 32 patients. 47% of them were for generic drugs. CMS names the drug for 124 of them, across 4 drugs with 11 or more claims each, at $1,599,701 in total drug cost. In 2023, CMS named 142 claims across 5 drugs.

Dr. Colombel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Colombel as offering telehealth.

Dmand AI links Dr. Colombel to 2 clinical trials. Conditions studied include Abdominal Pain, Colitis, Ulcerative and Colitis. Open Payments lists research payments to Dr. Colombel that name 3 trials.

CMS Open Payments shows 874 general payments to Dr. Colombel from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Abbvie Inc. paid the most, $355,433. It also lists 37 research payments totaling $78,163 from 2016 to 2025, naming 3 clinical trials.

Dr. Colombel graduated from Other in 1984.